Arix Bioscience (ARIX) News Today GBX 142 0.00 (0.00%) (As of 02/12/2024) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 22, 2024 | msn.comEconomy Minister Jeremy Miles on business support, entrepreneurship and the development bankApril 17, 2024 | finance.yahoo.comSphere Fluidics Appoints Edward Rayner as Non-Executive DirectorApril 9, 2024 | finance.yahoo.comArix Bioscience PLC (3HY.SG)March 22, 2024 | msn.comLife sciences firm ReNeuron which received £13m in Welsh Government support enters administrationMarch 18, 2024 | seekingalpha.comAcacia Research: Positive Developments, Discount To Book Value High Despite Recent Price SpikeMarch 15, 2024 | finance.yahoo.comAcacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Call TranscriptFebruary 12, 2024 | markets.businessinsider.comSuspension of Trading in SharesJanuary 9, 2024 | finanznachrichten.deArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)January 8, 2024 | finanznachrichten.deArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be -3-January 8, 2024 | finance.yahoo.comWith 40% ownership, Arix Bioscience plc (LON:ARIX) has piqued the interest of institutional investorsJanuary 5, 2024 | finanznachrichten.deArix Bioscience PLC: Publication of Circular and RTW Bio Prospectus -2-January 5, 2024 | markets.businessinsider.comPublication of Circular and RTW Bio ProspectusDecember 22, 2023 | finanznachrichten.deArix Bioscience PLC: Update regarding timing of Proposed Scheme of ReconstructionDecember 22, 2023 | markets.businessinsider.comUpdate regarding timing of Proposed Scheme of ReconstructionDecember 8, 2023 | markets.businessinsider.comPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialDecember 4, 2023 | thetimes.co.ukThorny case for Arix chief to answerNovember 19, 2023 | thetimes.co.ukArix Bioscience board’s Caribbean meeting left shareholders ‘flabbergasted’November 15, 2023 | finanznachrichten.deCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockNovember 14, 2023 | finance.yahoo.comAcacia Research Corporation (NASDAQ:ACTG) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comQ3 2023 Acacia Research Corp Earnings CallNovember 13, 2023 | finance.yahoo.comAcacia Research Corp (ACTG) Reports Mixed Q3 Results Amid Strategic ShiftsNovember 12, 2023 | msn.comBroker Peel Hunt Ditches Arix Over Terms of Takeover DealNovember 10, 2023 | thetimes.co.ukBroker quits Arix over RTW takeoverNovember 9, 2023 | thetimes.co.ukDon’t swallow dog’s breakfast deal at Arix BioscienceNovember 5, 2023 | morningstar.comArix Bioscience PLC ARIXNovember 2, 2023 | thetimes.co.ukAmerican investment firm swoops for Arix BioscienceNovember 1, 2023 | markets.businessinsider.comPortfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102November 1, 2023 | finanznachrichten.deArix Bioscience PLC: Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102November 1, 2023 | lse.co.ukRTW Biotech agrees "immediately accretive" Arix Bioscience takeoverNovember 1, 2023 | marketwatch.comRTW Biotech to Buy Arix Bioscience Assets, Swelling PortfolioOctober 19, 2023 | markets.businessinsider.comActimed Therapeutics Appoints Martin Walton as Chief Financial OfficerSeptember 27, 2023 | thetimes.co.ukArix Bioscience boss set to leave as wind-down loomsSeptember 27, 2023 | marketwatch.comArix Bioscience CEO Steps DownJuly 30, 2023 | thetimes.co.ukStrategic review of Arix Bioscience after activist pressureJuly 30, 2023 | finance.yahoo.comArix Bioscience plc (LON:ARIX) is definitely on the radar of institutional investors who own 40% of the companyJuly 13, 2023 | thetimes.co.ukBiotech firm backed by Neil Woodford ponders wind-downJuly 13, 2023 | lse.co.ukArix Bioscience launches strategic review despite value increaseJuly 13, 2023 | markets.businessinsider.comArix Announces Strategic ReviewJuly 13, 2023 | marketwatch.comArix Bioscience Begins Strategic Review, Says Winding-Down Is an OptionJune 23, 2023 | uk.news.yahoo.comPortfolio company Disc Medicine raises $157.8 million in public offeringJune 9, 2023 | markets.businessinsider.comPortfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHAJune 9, 2023 | uk.movies.yahoo.comUnaudited NAV for May 2023June 9, 2023 | finanznachrichten.deArix Bioscience PLC: Unaudited NAV for May 2023May 24, 2023 | markets.businessinsider.comCorrection: Result of Annual General MeetingMay 24, 2023 | finanznachrichten.deArix Bioscience PLC: Result of Annual General MeetingMay 16, 2023 | markets.businessinsider.comPortfolio company Ensoma announces closing of Series B ExtensionMay 16, 2023 | finanznachrichten.deArix Bioscience PLC: Portfolio company Ensoma announces closing of Series B ExtensionMay 12, 2023 | finanznachrichten.deArix Bioscience PLC: Unaudited NAV for April 2023May 5, 2023 | finance.yahoo.comIndependent Non-Executive Chairman of Arix Bioscience Picks Up 14% More Stock \April 27, 2023 | finanznachrichten.deArix Bioscience PLC: Arix Co-leads USD50 Million Series B Financing for New Portfolio Company Evommune Get Arix Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter. Email Address How a $0.25 cent option contract makes my top traders feel (Ad)If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently… Click now to see for yourself what $0.25 Cent Trades is all about ARIX Media Mentions By Week ARIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARIX News Sentiment▼0.000.62▲Average Medical News Sentiment ARIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARIX Articles This Week▼00▲ARIX Articles Average Week Get Arix Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ergomed News Today PureTech Health News Today Oxford Biomedica News Today Bioventix News Today hVIVO News Today Scancell News Today Futura Medical News Today Faron Pharmaceuticals Oy News Today Poolbeg Pharma News Today Redx Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:ARIX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arix Bioscience plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arix Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARIX Stock Alerts